nodes	percent_of_prediction	percent_of_DWPC	metapath
Amrinone—TNF—osteoporosis	0.896	1	CbGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—LRP5—osteoporosis	0.00127	0.0123	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—NFATC1—osteoporosis	0.00125	0.0121	CbGpPWpGaD
Amrinone—TNF—RXR and RAR heterodimerization with other nuclear receptor—VDR—osteoporosis	0.00122	0.0118	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—LRP6—osteoporosis	0.00122	0.0117	CbGpPWpGaD
Amrinone—TNF—Transcription factor regulation in adipogenesis—IRS2—osteoporosis	0.00114	0.011	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—WNT1—osteoporosis	0.00113	0.0109	CbGpPWpGaD
Amrinone—TNF—Transcription factor regulation in adipogenesis—LEP—osteoporosis	0.00112	0.0108	CbGpPWpGaD
Amrinone—PDE3A—G alpha (s) signalling events—PTH—osteoporosis	0.00107	0.0103	CbGpPWpGaD
Amrinone—PDE4B—G alpha (s) signalling events—PTH—osteoporosis	0.00102	0.00983	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—NFATC1—osteoporosis	0.001	0.00967	CbGpPWpGaD
Amrinone—PDE4B—Myometrial Relaxation and Contraction Pathways—ACTG1—osteoporosis	0.001	0.00967	CbGpPWpGaD
Amrinone—TNF—Type II diabetes mellitus—IRS1—osteoporosis	0.000998	0.00963	CbGpPWpGaD
Amrinone—TNF—Transcription factor regulation in adipogenesis—IRS1—osteoporosis	0.000998	0.00963	CbGpPWpGaD
Amrinone—TNF—amb2 Integrin signaling—AGER—osteoporosis	0.000972	0.00937	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—GAPDH—osteoporosis	0.000914	0.00882	CbGpPWpGaD
Amrinone—TNF—Apoptosis—GSN—osteoporosis	0.000896	0.00865	CbGpPWpGaD
Amrinone—PDE3A—G alpha (s) signalling events—PTHLH—osteoporosis	0.000888	0.00856	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—WNT1—osteoporosis	0.000847	0.00817	CbGpPWpGaD
Amrinone—PDE4B—G alpha (s) signalling events—PTHLH—osteoporosis	0.000845	0.00815	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—GPX1—osteoporosis	0.000841	0.00811	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—WDR1—osteoporosis	0.000838	0.00808	CbGpPWpGaD
Amrinone—PDE3A—G alpha (s) signalling events—CALCA—osteoporosis	0.000782	0.00754	CbGpPWpGaD
Amrinone—PDE4B—Opioid Signalling—ADCY5—osteoporosis	0.000744	0.00717	CbGpPWpGaD
Amrinone—PDE4B—G alpha (s) signalling events—CALCA—osteoporosis	0.000744	0.00717	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—IRAK3—osteoporosis	0.000741	0.00715	CbGpPWpGaD
Amrinone—TNF—Cellular roles of Anthrax toxin—IL1B—osteoporosis	0.000713	0.00688	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—SOD2—osteoporosis	0.000697	0.00672	CbGpPWpGaD
Amrinone—PDE4B—G Protein Signaling Pathways—ADCY5—osteoporosis	0.000666	0.00642	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—CAP1—osteoporosis	0.000662	0.00639	CbGpPWpGaD
Amrinone—TNF—IL27-mediated signaling events—IL1B—osteoporosis	0.000624	0.00602	CbGpPWpGaD
Amrinone—PDE4B—Myometrial Relaxation and Contraction Pathways—CALCA—osteoporosis	0.000622	0.006	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—SPP1—osteoporosis	0.000617	0.00595	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—MTHFR—osteoporosis	0.000614	0.00592	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—IL1B—osteoporosis	0.000606	0.00584	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.000592	0.00571	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—SOD2—osteoporosis	0.000567	0.00547	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—WNT1—osteoporosis	0.000557	0.00537	CbGpPWpGaD
Amrinone—PDE3A—G alpha (s) signalling events—ADCY5—osteoporosis	0.000556	0.00536	CbGpPWpGaD
Amrinone—PDE4B—Opioid Signalling—POMC—osteoporosis	0.000547	0.00527	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—GPX1—osteoporosis	0.000541	0.00522	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.00053	0.00511	CbGpPWpGaD
Amrinone—PDE4B—G alpha (s) signalling events—ADCY5—osteoporosis	0.000529	0.0051	CbGpPWpGaD
Amrinone—TNF—Monoamine Transport—IL1B—osteoporosis	0.000529	0.0051	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—MGLL—osteoporosis	0.000526	0.00507	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—BMP2—osteoporosis	0.000504	0.00486	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—MTHFR—osteoporosis	0.000499	0.00481	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—IGF1—osteoporosis	0.000495	0.00478	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—RAP1A—osteoporosis	0.000487	0.0047	CbGpPWpGaD
Amrinone—TNF—IL27-mediated signaling events—TGFB1—osteoporosis	0.000485	0.00468	CbGpPWpGaD
Amrinone—TNF—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—osteoporosis	0.000485	0.00468	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—PLEK—osteoporosis	0.000481	0.00464	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—ANXA2—osteoporosis	0.000481	0.00464	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—NFATC1—osteoporosis	0.000475	0.00458	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—IL1B—osteoporosis	0.000471	0.00454	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—TGFB1—osteoporosis	0.000471	0.00454	CbGpPWpGaD
Amrinone—TNF—Overview of nanoparticle effects—IL6—osteoporosis	0.00047	0.00453	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—SOD2—osteoporosis	0.00045	0.00434	CbGpPWpGaD
Amrinone—TNF—Cardiac Hypertrophic Response—IGF1—osteoporosis	0.000444	0.00429	CbGpPWpGaD
Amrinone—PDE4B—Myometrial Relaxation and Contraction Pathways—ADCY5—osteoporosis	0.000442	0.00427	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000439	0.00424	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—GPX1—osteoporosis	0.00043	0.00414	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—CALCR—osteoporosis	0.000419	0.00404	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—PTH1R—osteoporosis	0.000419	0.00404	CbGpPWpGaD
Amrinone—TNF—Transcription factor regulation in adipogenesis—IL6—osteoporosis	0.000418	0.00403	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—TLN1—osteoporosis	0.000415	0.004	CbGpPWpGaD
Amrinone—TNF—Apoptosis—PSMA2—osteoporosis	0.000414	0.00399	CbGpPWpGaD
Amrinone—TNF—Apoptosis—PSMA5—osteoporosis	0.000414	0.00399	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—LEP—osteoporosis	0.000411	0.00396	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—VCL—osteoporosis	0.000409	0.00395	CbGpPWpGaD
Amrinone—PDE3A—G alpha (s) signalling events—POMC—osteoporosis	0.000409	0.00394	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—PTH1R—osteoporosis	0.000398	0.00384	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—CALCR—osteoporosis	0.000398	0.00384	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—CAP1—osteoporosis	0.000398	0.00384	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000397	0.00382	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000395	0.00381	CbGpPWpGaD
Amrinone—PDE4B—G alpha (s) signalling events—POMC—osteoporosis	0.000389	0.00375	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—PTH1R—osteoporosis	0.00038	0.00367	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—CALCR—osteoporosis	0.00038	0.00367	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—SPP1—osteoporosis	0.000371	0.00358	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000368	0.00355	CbGpPWpGaD
Amrinone—TNF—IL27-mediated signaling events—IL6—osteoporosis	0.000366	0.00353	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—IL1B—osteoporosis	0.000364	0.00351	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—PTH1R—osteoporosis	0.000362	0.00349	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—CALCR—osteoporosis	0.000362	0.00349	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—IL6—osteoporosis	0.000355	0.00342	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—RAP1A—osteoporosis	0.000342	0.0033	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—MGLL—osteoporosis	0.000332	0.00321	CbGpPWpGaD
Amrinone—TNF—Apoptosis—IGF1—osteoporosis	0.000317	0.00305	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—IGF1—osteoporosis	0.000317	0.00305	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—MGLL—osteoporosis	0.000316	0.00305	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000313	0.00302	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—FGA—osteoporosis	0.00031	0.00299	CbGpPWpGaD
Amrinone—TNF—amb2 Integrin signaling—IL6—osteoporosis	0.00031	0.00299	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.000308	0.00297	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000307	0.00296	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—MGLL—osteoporosis	0.000302	0.00291	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—MYC—osteoporosis	0.000298	0.00287	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—IL1B—osteoporosis	0.000296	0.00286	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—LEP—osteoporosis	0.000292	0.00282	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—SPP1—osteoporosis	0.000289	0.00279	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—MGLL—osteoporosis	0.000287	0.00277	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—FGB—osteoporosis	0.000282	0.00272	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—IRS2—osteoporosis	0.000276	0.00266	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—IL6—osteoporosis	0.000276	0.00266	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—TGFB1—osteoporosis	0.00027	0.00261	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—LEP—osteoporosis	0.00027	0.00261	CbGpPWpGaD
Amrinone—TNF—Cardiac Hypertrophic Response—TGFB1—osteoporosis	0.000266	0.00257	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—IL1B—osteoporosis	0.000257	0.00247	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—IL1B—osteoporosis	0.000257	0.00247	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—TLN1—osteoporosis	0.000249	0.0024	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—IL6—osteoporosis	0.000249	0.0024	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—SOST—osteoporosis	0.000248	0.00239	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—ACTG1—osteoporosis	0.000246	0.00237	CbGpPWpGaD
Amrinone—PDE4B—Myometrial Relaxation and Contraction Pathways—IL1B—osteoporosis	0.000241	0.00233	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—IRS1—osteoporosis	0.000241	0.00232	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—SOST—osteoporosis	0.000236	0.00228	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—IL1B—osteoporosis	0.000235	0.00227	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PTH1R—osteoporosis	0.000225	0.00217	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CALCR—osteoporosis	0.000225	0.00217	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—IGF1—osteoporosis	0.000223	0.00215	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—PTH—osteoporosis	0.00022	0.00212	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—CNR2—osteoporosis	0.000214	0.00207	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PTH1R—osteoporosis	0.000214	0.00206	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CALCR—osteoporosis	0.000214	0.00206	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—IL6—osteoporosis	0.000213	0.00206	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—IL1B—osteoporosis	0.000209	0.00202	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—PTH—osteoporosis	0.000209	0.00202	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—CNR2—osteoporosis	0.000204	0.00197	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—osteoporosis	0.000204	0.00196	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—PTH—osteoporosis	0.0002	0.00193	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—TGFB1—osteoporosis	0.000199	0.00192	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000196	0.00189	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—CNR2—osteoporosis	0.000195	0.00188	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—WNT1—osteoporosis	0.000192	0.00185	CbGpPWpGaD
Amrinone—TNF—Apoptosis—MYC—osteoporosis	0.00019	0.00184	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—PTH—osteoporosis	0.00019	0.00183	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoporosis	0.00019	0.00183	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.00019	0.00183	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—IL1B—osteoporosis	0.000186	0.0018	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—CNR2—osteoporosis	0.000185	0.00178	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—WNT1—osteoporosis	0.000183	0.00176	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—PTHLH—osteoporosis	0.000182	0.00176	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—MGLL—osteoporosis	0.000178	0.00172	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—LRP5—osteoporosis	0.000174	0.00168	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—WNT1—osteoporosis	0.000174	0.00168	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—IL6—osteoporosis	0.000173	0.00167	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—PTHLH—osteoporosis	0.000173	0.00167	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—MGLL—osteoporosis	0.00017	0.00164	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—LRP6—osteoporosis	0.000167	0.00161	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—LRP5—osteoporosis	0.000166	0.0016	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—PTHLH—osteoporosis	0.000165	0.0016	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000164	0.00158	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—IL1B—osteoporosis	0.000163	0.00157	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—CALCA—osteoporosis	0.00016	0.00155	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—LRP6—osteoporosis	0.000158	0.00153	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—PTHLH—osteoporosis	0.000157	0.00152	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—CALCA—osteoporosis	0.000153	0.00147	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000149	0.00144	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—CALCA—osteoporosis	0.000146	0.0014	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—MYC—osteoporosis	0.000145	0.0014	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—TGFB1—osteoporosis	0.000145	0.00139	CbGpPWpGaD
Amrinone—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—osteoporosis	0.000141	0.00136	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TLN1—osteoporosis	0.000141	0.00136	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—IL1B—osteoporosis	0.00014	0.00135	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—CALCA—osteoporosis	0.000139	0.00134	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—IL6—osteoporosis	0.000138	0.00133	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—TGFB1—osteoporosis	0.000134	0.00129	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TLN1—osteoporosis	0.000134	0.00129	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—IL6—osteoporosis	0.000133	0.00128	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—IGF1—osteoporosis	0.000128	0.00123	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—IL6—osteoporosis	0.000122	0.00118	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—P4HB—osteoporosis	0.000121	0.00117	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PTH—osteoporosis	0.000118	0.00114	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—RAP1A—osteoporosis	0.000116	0.00112	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—P4HB—osteoporosis	0.000115	0.00111	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CNR2—osteoporosis	0.000115	0.00111	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—ADCY5—osteoporosis	0.000114	0.0011	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—NFATC1—osteoporosis	0.000113	0.00109	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—DKK1—osteoporosis	0.000112	0.00108	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PTH—osteoporosis	0.000112	0.00108	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—RAP1A—osteoporosis	0.00011	0.00106	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CNR2—osteoporosis	0.000109	0.00105	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—MYC—osteoporosis	0.000109	0.00105	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—TGFB1—osteoporosis	0.000109	0.00105	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—IL6—osteoporosis	0.000109	0.00105	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—ADCY5—osteoporosis	0.000109	0.00105	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—WNT1—osteoporosis	0.000108	0.00104	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—NFATC1—osteoporosis	0.000108	0.00104	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—DKK1—osteoporosis	0.000107	0.00103	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—FGA—osteoporosis	0.000105	0.00101	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—ADCY5—osteoporosis	0.000104	0.000999	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—WNT1—osteoporosis	0.000103	0.000991	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—IL6—osteoporosis	0.000101	0.000973	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—FGA—osteoporosis	0.0001	0.000964	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	9.86e-05	0.000951	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—ADCY5—osteoporosis	9.85e-05	0.00095	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	9.84e-05	0.000949	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PTHLH—osteoporosis	9.77e-05	0.000943	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—BMP2—osteoporosis	9.77e-05	0.000943	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—FGB—osteoporosis	9.56e-05	0.000922	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—IL6—osteoporosis	9.56e-05	0.000922	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PTHLH—osteoporosis	9.3e-05	0.000897	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—BMP2—osteoporosis	9.3e-05	0.000897	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—LEP—osteoporosis	9.29e-05	0.000896	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PSMA2—osteoporosis	9.23e-05	0.00089	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PSMA5—osteoporosis	9.23e-05	0.00089	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—FGB—osteoporosis	9.1e-05	0.000877	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PSMA5—osteoporosis	8.78e-05	0.000847	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PSMA2—osteoporosis	8.78e-05	0.000847	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—IL6—osteoporosis	8.72e-05	0.000841	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CALCA—osteoporosis	8.6e-05	0.00083	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—POMC—osteoporosis	8.39e-05	0.000809	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CALCA—osteoporosis	8.18e-05	0.000789	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—POMC—osteoporosis	7.98e-05	0.00077	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—KL—osteoporosis	7.81e-05	0.000754	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—IL6R—osteoporosis	7.78e-05	0.000751	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—TGFB1—osteoporosis	7.66e-05	0.000738	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—POMC—osteoporosis	7.62e-05	0.000735	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—IL6R—osteoporosis	7.43e-05	0.000717	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—KL—osteoporosis	7.43e-05	0.000717	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—POMC—osteoporosis	7.25e-05	0.000699	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—IL6R—osteoporosis	7.07e-05	0.000682	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—ADCY5—osteoporosis	6.12e-05	0.00059	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—SPP1—osteoporosis	5.92e-05	0.000571	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—ADCY5—osteoporosis	5.82e-05	0.000561	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—SPP1—osteoporosis	5.63e-05	0.000543	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—IRS2—osteoporosis	5.35e-05	0.000516	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—LEP—osteoporosis	5.24e-05	0.000505	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—IRS2—osteoporosis	5.09e-05	0.000491	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—ESR1—osteoporosis	5e-05	0.000483	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—LEP—osteoporosis	4.98e-05	0.000481	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—ESR1—osteoporosis	4.76e-05	0.000459	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—IRS1—osteoporosis	4.67e-05	0.000451	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—TGFB1—osteoporosis	4.6e-05	0.000444	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—POMC—osteoporosis	4.5e-05	0.000434	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—IRS1—osteoporosis	4.45e-05	0.000429	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—IL6R—osteoporosis	4.39e-05	0.000424	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—IGF1—osteoporosis	4.33e-05	0.000418	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—POMC—osteoporosis	4.28e-05	0.000413	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—IL6R—osteoporosis	4.18e-05	0.000403	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—IGF1—osteoporosis	4.12e-05	0.000397	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—IL6—osteoporosis	3.47e-05	0.000334	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—IL6—osteoporosis	3.31e-05	0.000319	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—IL6—osteoporosis	3.15e-05	0.000304	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—MYC—osteoporosis	2.6e-05	0.000251	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TGFB1—osteoporosis	2.6e-05	0.00025	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—MYC—osteoporosis	2.48e-05	0.000239	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TGFB1—osteoporosis	2.47e-05	0.000238	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—IL6—osteoporosis	1.96e-05	0.000189	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—IL6—osteoporosis	1.86e-05	0.000179	CbGpPWpGaD
